Cosmetic Supervision and Sampling Inspection Data and Information Sharing – October 2025

Nov 17, 2025
China
Cosmetics
Want to see the full content? Sign up for free today and get 1 hour of expert consultation included!

In October 2025, the provincial Medical Products Administrations (MPAs) of Shanghai, Shanxi, Jiangxi, Jiangsu, and Hunan successively issued public notices. A total of 48 batches of products were found to be non-compliant with regulations.

This article provides a consolidated overview of the relevant regulatory notices, supplemented by recent developments in regulatory enforcement activities – such as unannounced inspections and sampling inspections – conducted by the National Medical Products Administration (NMPA) and selected provincial and municipal authorities. The aim is to assist enterprises in staying informed of evolving regulatory trends and to reinforce awareness of quality management and compliance requirements.

China,Cosmetic,Supervision,Sampling,Inspection,Information

Cosmetic Supervision and Sampling Inspection Data

Shanghai Municipal Medical Products Administration Notice on the Results of the First Batch of Cosmetic Supervision and Sampling Inspection in 2025

On October 9, 2025, the Shanghai Municipal Medical Products Administration issued a notice to strengthen the supervision and administration of cosmetic quality, regulate market order, and ensure the safe use of cosmetics by consumers. The Shanghai Administration organized a quality supervision and sampling inspection of cosmetic manufacturing and distribution enterprises in Shanghai. A total of 15 batches of cosmetics were found to be non-compliant.

The non-compliant cosmetics include body wash, hair dye cream, and styling spray, among others. The reasons for non-compliance include total bacterial count, ingredient consistency, flagging ingredients such as phenol, minoxidil, piroctone olamine, and methanol.

https://yjj.sh.gov.cn/zx-hzp/20251013/7bbd8cced9974d8981195ea7d97e766a.html

Shanxi Provincial Medical Products Administration Notice on Three Batches of Non-Compliant Cosmetics

On October 11, 2025, the Shanxi Provincial Medical Products Administration issued a notice regarding the cosmetic sampling and testing conducted in Shanxi Province in 2024. According to the testing results from the Shanxi Testing and Inspection Center (Shanxi Institute of Standardization and Metrology), a total of three batches of body wash products were found to be non-compliant.

The non-compliant items were all related to physicochemical testing of cosmetics – specifically, the presence of a mixture of methylchloroisothiazolinone and methylisothiazolinone with magnesium chloride and magnesium nitrate (in a ratio of 3:1 for methylchloroisothiazolinone to methylisothiazolinone).

https://yjj.shanxi.gov.cn/xxfb/gsgg/202510/t20251011_9973878.shtml

Jiangxi Provincial Medical Products Administration Announcement on the Third Batch of Cosmetic Supervision and Sampling Inspection in 2025

On October 16, 2025, the Jiangxi Provincial Medical Products Administration issued an announcement stating that, in accordance with the 2025 Provincial Cosmetic Supervision and Sampling Inspection Work Plan, continuous supervision and sampling inspections have been carried out across the province, covering both production and distribution stages of cosmetics.

In this batch of inspections, a total of 12 batches of cosmetics were found to be non-compliant, including six batches of hair dye cream, two batches of sunscreen cream, two batches of sunscreen spray, one batch of shampoo, and one batch of body wash. The non-compliant items involved include phenylmethyl pyrazolone, toluene-2,5-diamine sulfate, m-aminophenol, 2-methylresorcinol, 2-amino-3-hydroxypyridine, and N,N-bis(2-hydroxyethyl)-p-phenylenediamine sulfate, etc.

https://mpa.jiangxi.gov.cn/jxsypjdglj/col/col45622/content/content_1978649540463890432.html

Jiangsu Provincial Medical Products Administration Notice on 17 Batches of Non-Compliant Cosmetics (2025, No. 5)

On October 24, 2025, the Jiangsu Provincial Medical Products Administration issued its fifth notice of the year, announcing the results of cosmetic sampling inspections conducted in accordance with the annual inspection plan. Sampling was carried out across various cosmetic manufacturers and distributors throughout the province. A total of 17 batches of cosmetics were found to be non-compliant with regulatory standards.

The non-compliant products included gel nail polish, freckle-removing creams, and sunscreen sprays. The items failed due to the presence of prohibited or restricted substances such as dichloromethane, 2-amino-3-hydroxypyridine, benzene, chloramphenicol, and terbinafine.

https://da.jiangsu.gov.cn/art/2025/10/24/art_84625_11664845.html

Hunan Provincial Medical Products Administration Notice on One Batch of Non-Compliant Cosmetic Product (2025, No. 10)

On October 31, 2025, in accordance with the Hunan Provincial 2025 Cosmetic Sampling and Testing Plan, the Hunan Provincial Medical Products Administration conducted sampling inspections of cosmetic products manufactured and distributed across the province. One batch of acne treatment essence water was found to be non-compliant. The non-compliant ingredients detected were metronidazole and chloramphenicol, both of which are prohibited for use in cosmetic products.

https://mpa.hunan.gov.cn/mpa/xxgk/tzgg/wjtz/202510/t20251031_33839031.html

Information Sharing

NMPA Announcement on the Results of a Surprise Inspection of Gansu Dashouyin Rose Technology Co., Ltd. (2025, No. 36)

On October 20, 2025, the NMPA released the results of a recent surprise inspection conducted on Gansu Dashouyin Rose Technology Co., Ltd. The inspection revealed that the company had violated relevant provisions of the Regulations on the Supervision and Administration of Cosmetics and the Good Manufacturing Practices for Cosmetics. Serious deficiencies were found in the company’s production quality management system. As of now, the Gansu authority has initiated a formal investigation, ordered the company to suspend its production and business operations, and required it to carry out corrective measures to address the identified issues.

https://www.nmpa.gov.cn/xxgk/fxjzh/hzhpfxjch/hzhpfxjcgjj/20251020171409123.html

Guangzhou Completes Special Sampling Inspection of 2,066 Cosmetic Batches-40 Found Non-Compliant

On October 24, 2025, the Guangzhou Municipal Administration for Market Regulation announced the results of its 2024 Special Sampling Inspection Program for Cosmetics. A total of 2,066 batches of cosmetics (including enforcement sampling) were inspected citywide. Among them, 2,026 batches met regulatory requirements, while 40 batches were found to be non-compliant.

The non-compliant products spanned nine categories:

  • Sunscreens
  • Face masks
  • General skincare and miscellaneous products
  • Spot-removal and whitening products
  • Hair dyes, perms, and hair growth treatments
  • Shampoos, conditioners, and body cleansers
  • Acne-treatment products
  • Toothpastes
  • Skincare products for infants and children

https://www.gz.gov.cn/zwgk/zdly/cpzljgzf/ccgg/content/post_10497266.html?sessionid=

Linxia, Gansu, Launches One-Month Special Inspection of Online Cosmetic Sales and Beauty Service Venues

Recently, the Linxia Prefecture Administration for Market Regulation in Gansu Province carried out a one-month special inspection targeting cosmetic e-commerce operations and beauty service establishments within its jurisdiction.

Following the principle of “consistency between online and offline operations”, the inspection focused on several key areas:

  • Identifying and documenting all entities engaged in online cosmetic sales and beauty services to establish a comprehensive regulatory ledger;
  • Investigating and removing counterfeit cosmetics, unlicensed cosmetic production, unregistered or unfiled products, non-compliant products that fail to meet mandatory national standards, and those under sales suspension – especially those sold or used via online platforms and beauty salons; and
  • Cracking down on illegal advertising, particularly misleading claims suggesting medical efficacy or other prohibited indications related to cosmetic functions.

During the inspection period, a total of 252 cosmetic e-commerce businesses and beauty service venues were inspected. Authorities issued 91 rectification orders and investigated 8 cases of regulatory violations. (Source: China Food and Drug Network)

About CIRS

The CIRS cosmetic team is dedicated to ensuring that cosmetic products meet stringent global regulatory standards. It can provide one-stop services covering the whole life-cycle of a personal care product, which includes cosmetic ingredient development, physical/chemical tests, toxicological tests (in vivo & in vitro), efficacy studies (in vivo & in vitro), ingredient registration, and product registration.

Cosmetic services in China:

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

GlobalCosing Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: GlobalCosing" on this website are copyrighted by GlobalCosing. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: GlobalCosing" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: GlobalCosing" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on GlobalCosing raises copyright or other related issues, please contact us within two weeks.

Latest Laws & Standards
No data
Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.